Harbor Investment Advisory’s Vir Biotechnology VIR Stock Holding History

Harbor Investment Advisory’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-30	Closed	-$267	–	1310
2024 Q2	$267	Hold	30	–	–	﹤0.01%	1159
2024 Q1	$304	Hold	30	–	–	﹤0.01%	1273
2023 Q4	$302	Hold	30	–	–	﹤0.01%	1122
2023 Q3	$281	Hold	30	–	–	﹤0.01%	1144
2023 Q2	$736	Hold	30	–	–	﹤0.01%	1270
2023 Q1	$698	Hold	30	–	–	﹤0.01%	1273
2022 Q4	$759	Hold	30	–	–	﹤0.01%	1270
2022 Q3	$1K	Hold	30	–	–	﹤0.01%	1307
2022 Q2	$1K	Hold	30	–	–	﹤0.01%	1317
2022 Q1	$1K	Hold	30	–	–	﹤0.01%	1316
2021 Q4	$1K	Hold	30	–	–	﹤0.01%	1284
2021 Q3	$1K	Hold	30	–	–	﹤0.01%	1288
2021 Q2	$1K	Hold	30	–	–	﹤0.01%	1231
2021 Q1	$2K	Hold	30	–	–	﹤0.01%	1188
2020 Q4	$1K	Buy	+30	New	+$975	﹤0.01%	1175

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Harbor Investment Advisory's VIR Position: Q3 2024 in Review

Harbor Investment Advisory sold out of Vir Biotechnology (VIR) in Q3 2024, closing a stake of 30 shares — an estimated $267 sold.

Harbor Investment Advisory first reported a position in VIR in Q4 2020 and held it in 15 quarters. The position peaked at $2K in Q1 2021. 197 funds tracked by Wall St. Rank hold VIR as of Q3 2024.

Harbor Investment Advisory reported no remaining Vir Biotechnology position as of Q3 2024 after selling out during the quarter.
Harbor Investment Advisory sold 30 Vir Biotechnology shares in Q3 2024, an estimated $267.
Harbor Investment Advisory first reported a position in Vir Biotechnology in Q4 2020 and held it in 15 quarters.
Harbor Investment Advisory's Vir Biotechnology position peaked at $2K in Q1 2021.
197 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2024.

Based on Harbor Investment Advisory's 13F filing for Q3 2024, filed 4 Oct 2024.